다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
The journal of clinical hypertension, v.18 no.1, 2016년, pp.60 - 69
Rump, Lars C. (Department of Nephrology Medical Faculty Heinrich‐) , Ammentorp, Bettina (Heine‐) , Laeis, Petra (University Dü) , Scholze, Jürgen (sseldorf Dü)
AI-Helper
This randomized, parallel‐group study in patients inadequately controlled on olmesartan medoxomil/amlodipine (OLM/AML) 40/10 mg assessed the effects of adding hydrochlorothiazide (HCTZ) 12.5 mg and 25 mg, using seated blood pressure (SeBP) measurements and ambulatory blood pressure (BP) monit...
1 Mancia G , Fagard R , Narkiewicz K , et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) . J Hypertens . 2013 ; 31 : 1281 – 1357 . 23817082
2 Jamerson K , Weber MA , Bakris GL , et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high‐risk patients . N Engl J Med . 2008 ; 359 : 2417 – 2428 . 19052124
3 Pepine CJ , Handberg EM , Cooper‐DeHoff RM , et al. A calcium antagonist vs a non‐calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil‐Trandolapril Study (INVEST): a randomized controlled trial . JAMA . 2003 ; 290 : 2805 – 2816 . 14657064
4 Hansson L , Zanchetti A , Carruthers SG , et al. Effects of intensive blood‐pressure lowering and low‐dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group . Lancet . 1998 ; 351 : 1755 – 1762 . 9635947
5 Banegas JR , Lopez‐Garcia E , Dallongeville J , et al. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study . Eur Heart J . 2011 ; 32 : 2143 – 2152 . 21471134
6 Volpe M , de la Sierra A , Kreutz R , et al. ARB‐based single‐pill platform to guide a practical therapeutic approach to hypertensive patients . High Blood Press Cardiovasc Prev . 2014 ; 21 : 137 – 147 . 24532183
7 Oparil S , Melino M , Lee J , et al. Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: the TRINITY multicenter, randomized, double‐blind, 12‐week, parallel‐group study . Clin Ther . 2010 ; 32 : 1252 – 1269 . 20678674
8 Volpe M , Rump LC , Ammentorp B , Laeis P . Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination . Clin Drug Investig . 2012 ; 32 : 649 – 664 .
9 Clement DL , De Buyzere ML , De Bacquer DA , et al. Prognostic value of ambulatory blood‐pressure recordings in patients with treated hypertension . N Engl J Med . 2003 ; 348 : 2407 – 2415 . 12802026
10 White WB , Giles T , Bakris GL , et al. Measuring the efficacy of antihypertensive therapy by ambulatory blood pressure monitoring in the primary care setting . Am Heart J . 2006 ; 151 : 176 – 184 . 16368314
11 Lovibond K , Jowett S , Barton P , et al. Cost‐effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study . Lancet . 2011 ; 378 : 1219 – 1230 . 21868086
12 Izzo JL Jr , Chrysant SG , Kereiakes D , et al. 24‐hour efficacy and safety of Triple‐Combination Therapy With Olmesartan, Amlodipine, and Hydrochlorothiazide: the TRINITY ambulatory blood pressure substudy . J Clin Hypertens (Greenwich) . 2011 ; 13 : 873 – 880 . 22142346
13 Mancia G , Laurent S , Agabiti‐Rosei E , et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document . J Hypertens . 2009 ; 27 : 2121 – 2158 . 19838131
14 Mancia G , De Backer G , Dominiczak A , et al. 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) . J Hypertens . 2007 ; 25 : 1105 – 1187 . 17563527
15 Volpe M , de la Sierra A , Ammentorp B , Laeis P . Open‐label study assessing the long‐term efficacy and safety of triple olmesartan/amlodipine/hydrochlorothiazide combination therapy for hypertension . Adv Ther . 2014 ; 31 : 561 – 574 . 24760656
16 Rump LC , Girerd X , Sellin L , Stegbauer J . Effects of high dose olmesartan medoxomil plus hydrochlorothiazide on blood pressure control in patients with grade 2 and grade 3 hypertension . J Hum Hypertens . 2010 ; 25 : 565 – 574 . 21107435
17 Volpe M , Brommer P , Haag U , Miele C . Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: a randomized, double‐blind, parallel‐group, multicentre study . Clin Drug Investig . 2009 ; 29 : 11 – 25 .
18 Lacourciere Y , Tytus R , O'Keefe D , et al. Efficacy and tolerability of a fixed‐dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapy . J Hum Hypertens . 2001 ; 15 : 763 – 770 . 11687919
19 Hall WD , Montoro R , Littlejohn T , et al. Efficacy and tolerability of valsartan in combination with hydrochlorothiazide in essential hypertension . Clin Drug Investig . 1998 ; 16 : 203 – 210 .
20 Chrysant SG , Bakris GL . Amlodipine/benazepril combination therapy for hypertensive patients nonresponsive to benazepril monotherapy . Am J Hypertens . 2004 ; 17 : 590 – 596 . 15233978
21 Schunkert H , Glazer RD , Wernsing M , et al. Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on amlodipine monotherapy . Curr Med Res Opin . 2009 ; 25 : 2655 – 2662 . 19751115
22 Blumenstein M , Romaszko J , Calderon A , et al. Antihypertensive efficacy and tolerability of aliskiren/hydrochlorothiazide (HCT) single‐pill combinations in patients who are non‐responsive to HCT 25 mg alone . Curr Med Res Opin . 2009 ; 25 : 903 – 910 . 19245300
23 Ke Y , Zhu D , Hong H , et al. Efficacy and safety of a single‐pill combination of amlodipine/valsartan in Asian hypertensive patients inadequately controlled with amlodipine monotherapy . Curr Med Res Opin . 2010 ; 26 : 1705 – 1713 . 20469975
24 Sinkiewicz W , Glazer RD , Kavoliuniene A , et al. Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on valsartan monotherapy . Curr Med Res Opin . 2009 ; 25 : 315 – 324 . 19192976
25 Mallion JM , Carretta R , Trenkwalder P , et al. Valsartan/hydrochlorothiazide is effective in hypertensive patients inadequately controlled by valsartan monotherapy . Blood Press . 2003 ; 12 : 36 – 43 .
26 Committee for Medicinal Products for Human Use . Guideline on clinical development of fixed combination medicinal products . European Medicines Agency 2008 ; CPMP/EWP/240/95 Rev. 1: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003686.pdf . Accessed June 30, 2015.
27 Committee for Medicinal Products for Human Use . Guideline on clinical investigation of medicinal products in the treatment of hypertension . European Medicines Agency 2009 ; CPMP/EWP/238/95 Rev. 3: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/12/WC500100191.pdf . Accessed June 30, 2015.
28 Scholze J , Schaefer A , Kreutz R . Safety and efficacy of olmesartan: an observational pooled‐analysis of 156,682 hypertensive patients . Expert Opin Drug Saf . 2011 ; 10 : 185 – 196 . 21254872
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 APC(Article Processing Charge)를 지불한 논문에 한하여 자유로운 이용이 가능한, hybrid 저널에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.